Czeglédy J, Gergely L, Hernádi Z, Póka R
Institute of Microbiology, University Medical School of Debrecen, Hungary.
Med Microbiol Immunol. 1989;178(6):309-14. doi: 10.1007/BF00197449.
A total of 336 biopsies, scrapes and exfoliated cells from the cervix and from the lower genital tract were screened for human papilloma (HP) viral sequences of types 6, 11, 16 and 18 by Southern blot, dot blot and filter in situ (FISH) hybridizations with cloned 32P-radiolabeled HPV DNA probes. The specimens included cervical intraepithelial neoplasias (CIN I-III), carcinoma in situ and invasive carcinoma of the cervix and vagina, adenocarcinomas, vulvar and vaginal condylomata acuminata and healthy epithelial samples. The oncogenic HPV 16 was found in 46% of the cervical carcinomas. Most of the type 16 occurrences (75%) represented the third stage of inoperable cases. Similarly, HPV 18 was also most frequently present in this stage as well as in carcinoma in situ and in CIN III (25%, 18%). At the same time, in condylomata acuminata, types 6 and 11 were detectable in 88.7% of cares. In all, 13.5% of the normal samples harboured HPV DNA.
采用Southern印迹法、斑点印迹法和滤膜原位(FISH)杂交技术,使用克隆的32P放射性标记的人乳头瘤病毒(HPV)DNA探针,对来自宫颈和下生殖道的336份活检组织、刮片及脱落细胞进行6型、11型、16型和18型人乳头瘤病毒(HPV)序列筛查。标本包括宫颈上皮内瘤变(CIN I - III)、宫颈原位癌和浸润癌、阴道癌、腺癌、外阴及阴道尖锐湿疣以及健康上皮样本。致癌性HPV 16在46%的宫颈癌中被发现。16型的大多数病例(75%)处于无法手术的第三阶段。同样,HPV 18在该阶段以及原位癌和CIN III中也最为常见(分别为25%、18%)。同时,在尖锐湿疣中,88.7%的病例可检测到6型和11型。总体而言,13.5%的正常样本携带HPV DNA。